{"protocolSection":{"identificationModule":{"nctId":"NCT04571099","orgStudyIdInfo":{"id":"XCY612-130814"},"organization":{"fullName":"Philips Clinical & Medical Affairs Global","class":"INDUSTRY"},"briefTitle":"Next Generation X-ray Imaging System","officialTitle":"Next Generation X-ray Imaging System"},"statusModule":{"statusVerifiedDate":"2022-03","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2020-10-08","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2021-03-26","type":"ACTUAL"},"completionDateStruct":{"date":"2021-03-26","type":"ACTUAL"},"studyFirstSubmitDate":"2020-09-04","studyFirstSubmitQcDate":"2020-09-25","studyFirstPostDateStruct":{"date":"2020-09-30","type":"ACTUAL"},"lastUpdateSubmitDate":"2023-11-15","lastUpdatePostDateStruct":{"date":"2023-11-18","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Philips Clinical & Medical Affairs Global","class":"INDUSTRY"}},"oversightModule":{"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"Philips Healthcare has developed a next generation Allura investigational device. The intended purpose of the investigational device is to perform neurovascular imaging applications, including diagnostic, interventional and minimally invasive procedures on human patients. The goal of this study is to investigate the accuracy of the next generation Allura investigational device to determine the extent and localization of ischemic stroke changes in brain tissue."},"conditionsModule":{"conditions":["Stroke, Acute"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":false,"designInfo":{"observationalModel":"COHORT","timePerspective":"PROSPECTIVE"},"enrollmentInfo":{"count":28,"type":"ACTUAL"}},"outcomesModule":{"primaryOutcomes":[{"measure":"Ischemic stroke diagnostic accuracy","description":"Accuracy of ASPECTS score to determine the extent and localization of ischemic stroke changes in brain tissue, evaluated by three independent neuroradiologists.","timeFrame":"Within 2 days after procedure"}],"secondaryOutcomes":[{"measure":"Vessel tree visibility","description":"Proportion of images made with new investigational device rated non-inferior vessel visibility compared to CTA (reference standard)","timeFrame":"Within 2 days after procedure"},{"measure":"Intracranial hemorrhage detection accuracy","description":"Accuracy of images made with new investigational device to determine the presence of intracranial hemorrhage using neCT as the reference standard","timeFrame":"Within 2 days after procedure"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. The patient has signed and dated the Informed Consent Form (ICF)\n2. Age ≥ 50 years old\n3. Clinical and radiological signs consistent with acute stroke I. Patient diagnosed with ischemic stroke of the anterior circulation and not eligible for thrombectomy. II. Patient diagnosed with ischemic stroke of the anterior circulation and subjected to thrombectomy. III. Patient diagnosed with hemorrhagic stroke.\n\nExclusion Criteria:\n\n1. Pregnant or breastfeeding women.\n2. Previous stroke or parenchymal damage/defects in anterior circulation territories (only applicable for subjects included by criterion 3.I or 3.II).\n3. Subject participates in a potentially confounding drug or device trial during the course of the study.\n4. Participation in the study exposes the subject to risk, as assessed at the discretion of the treating physician.\n5. All subjects who meet an exclusion criteria according to national law.\n6. Subject or subject family member is a known Philips employee.","healthyVolunteers":false,"sex":"ALL","minimumAge":"50 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"Patients with age 50 or older, of both genders. Patients are considered to be enrolled in the study after they have signed the informed consent form.","samplingMethod":"PROBABILITY_SAMPLE"},"contactsLocationsModule":{"overallOfficials":[{"name":"Michael Söderman, MD","affiliation":"Karolinska University Hospital","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Karolinska University Hospital","city":"Stockholm","country":"Sweden","geoPoint":{"lat":59.33258,"lon":18.0649}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14","submissionTracking":{"estimatedResultsFirstSubmitDate":"2023-11-30","submissionInfos":[{"releaseDate":"2023-11-30"}]}},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke, Acute","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}